These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7513466

  • 1. Role of nitric oxide in the pathogenesis of early pancreatic islet dysfunction during rat and human intraportal islet transplantation.
    Stevens RB, Lokeh A, Ansite JD, Field MJ, Gores PF, Sutherland DE.
    Transplant Proc; 1994 Apr; 26(2):692. PubMed ID: 7513466
    [No Abstract] [Full Text] [Related]

  • 2. Expression of intrahepatic inducible nitric oxide synthetase mRNA correlates with production of nitric oxide during intraportal isogeneic and allogeneic rat islet transplantation.
    Stevens RB, Ansite JD, Lokeh A, Rossini TJ, Mills CD, Sutherland DE.
    Transplant Proc; 1995 Feb; 27(1):615-6. PubMed ID: 7533428
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide production increases with intraportal islet xenograft transplantation.
    Behboo R, Lancaster JR, Nussler AK, Korbanic C, Rao AS, Ricordi C.
    Transplant Proc; 1994 Dec; 26(6):3448. PubMed ID: 7998215
    [No Abstract] [Full Text] [Related]

  • 4. Nitric oxide generation following intrahepatic human-to-rat islet transplantation is blocked by NG-monomethyl-L-arginine.
    Behboo R, Lancaster JR, Sweetland M, Korbanic C, Hoffman R, Simmons RL, Ricordi C.
    Transplant Proc; 1994 Apr; 26(2):776. PubMed ID: 8171659
    [No Abstract] [Full Text] [Related]

  • 5. Administration of NG-monomethyl-L-arginine in a marginal renal subcapsular mouse islet transplant model.
    Ansite JD, Stevens RB, Lokeh A, Brown RR, Saxena M, Mills CD, Sutherland DE.
    Transplant Proc; 1995 Feb; 27(1):605-6. PubMed ID: 7879115
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.
    Xenos ES, Stevens RB, Sutherland DE, Lokeh A, Ansite JD, Casanova D, Gores PF, Platt JL.
    Transplantation; 1994 Apr 27; 57(8):1208-12. PubMed ID: 8178348
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Morphologic evidence of reinnervation in intrahepatic islet allografts in rats.
    Noda N, Ina K, Shimada T, Yasunami Y, Ono J, Takaki R.
    Transplant Proc; 1994 Apr 27; 26(2):685-6. PubMed ID: 7909633
    [No Abstract] [Full Text] [Related]

  • 11. Recurrence of diabetes in a short time after intraportal but not spleen subcapsular islet transplantation in rats.
    Suzuki K, Aoyagi K, Ogawa Y, Katayama Y, Abe Y, Tazawa Y, Ishigame M, Kimura M, Takebe K.
    Transplant Proc; 1994 Apr 27; 26(2):684. PubMed ID: 8171610
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment with anti-VLA-4 and LFA-1 monoclonal antibodies prolongs intraportal rat islet allograft survival.
    Yang H, Issekutz TB, Wright JR.
    Transplant Proc; 1994 Dec 27; 26(6):3325-6. PubMed ID: 7998156
    [No Abstract] [Full Text] [Related]

  • 15. IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide.
    Xenos ES, Stevens RB, Gores PF, Casanova D, Farney AC, Sutherland DE, Platt JL.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 2):994. PubMed ID: 7680174
    [No Abstract] [Full Text] [Related]

  • 16. Surviving native beta-cells determine outcome of syngeneic intraportal islet transplantation.
    Hughes SJ, Powis SH, Press M.
    Cell Transplant; 2001 Feb 27; 10(2):145-51. PubMed ID: 11332628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel potent and selective inhibitors of inducible nitric oxide synthase.
    Nakane M, Klinghofer V, Kuk JE, Donnelly JL, Budzik GP, Pollock JS, Basha F, Carter GW.
    Mol Pharmacol; 1995 Apr 27; 47(4):831-4. PubMed ID: 7536889
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship.
    Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL.
    J Pharmacol Exp Ther; 1995 Feb 27; 272(2):945-52. PubMed ID: 7531767
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.